Search research articles
Contact Us
Filters
Showing results (21-30 of 235) with videos related to
Page
of 24
Sort By:
Nature Reviews. Molecular Cell Biology
|
March 24, 2007
p53 in health and disease
Karen H Vousden, David P Lane
Trends in Pharmacological Sciences
|
June 29, 2004
Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets?
Peter M Fischer, David P Lane
Transcription
|
August 14, 2012
How p53 wields the scales of fate: arrest or death?
Amanda M Goh, David P Lane
Cancer Discovery
|
January 9, 2023
Covalent Rescue of Mutant p53
David P Lane, Chandra S Verma
Journal of Molecular Biology
|
October 12, 2010
A novel unstructured scaffold based on 4EBP1 enables the functional display of a wide range of bioactive peptides
Hai Yun See, David P Lane
Frontiers in Pharmacology
|
May 16, 2022
An Automated Quantification Tool for Angiogenic Sprouting From Endothelial Spheroids
Pavitra Kannan, Martin Schain, David P Lane
Nature Reviews. Drug Discovery
|
December 2, 2008
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways
Anwesha Dey, Vinay Tergaonkar, David P Lane
Seminars in Cancer Biology
|
March 3, 2010
Modulating the p53 pathway
Anwesha Dey, David P Lane, Chandra S Verma
Cold Spring Harbor Perspectives in Biology
|
May 14, 2010
p53-based cancer therapy
David P Lane, Chit Fang Cheok, Sonia Lain
Scientific Reports
|
April 1, 2016
Long range recognition and selection in IDPs: the interactions of the C-terminus of p53
Srinivasaraghavan Kannan, David P Lane, Chandra S Verma
Page
of 24
Search research articles
Search
Showing results (21-30 of 235) with videos related to
Sort By:
Page
of 24
Nature Reviews. Molecular Cell Biology
|
March 24, 2007
p53 in health and disease
Karen H Vousden, David P Lane
Trends in Pharmacological Sciences
|
June 29, 2004
Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets?
Peter M Fischer, David P Lane
Transcription
|
August 14, 2012
How p53 wields the scales of fate: arrest or death?
Amanda M Goh, David P Lane
Cancer Discovery
|
January 9, 2023
Covalent Rescue of Mutant p53
David P Lane, Chandra S Verma
Journal of Molecular Biology
|
October 12, 2010
A novel unstructured scaffold based on 4EBP1 enables the functional display of a wide range of bioactive peptides
Hai Yun See, David P Lane
Frontiers in Pharmacology
|
May 16, 2022
An Automated Quantification Tool for Angiogenic Sprouting From Endothelial Spheroids
Pavitra Kannan, Martin Schain, David P Lane
Nature Reviews. Drug Discovery
|
December 2, 2008
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways
Anwesha Dey, Vinay Tergaonkar, David P Lane
Seminars in Cancer Biology
|
March 3, 2010
Modulating the p53 pathway
Anwesha Dey, David P Lane, Chandra S Verma
Cold Spring Harbor Perspectives in Biology
|
May 14, 2010
p53-based cancer therapy
David P Lane, Chit Fang Cheok, Sonia Lain
Scientific Reports
|
April 1, 2016
Long range recognition and selection in IDPs: the interactions of the C-terminus of p53
Srinivasaraghavan Kannan, David P Lane, Chandra S Verma
Page
of 24